J J Finance Corp (523062)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹32.58 |
| Market Cap | ₹9.23 Cr |
| P/E Ratio | 0 |
| ROCE | 4.57% |
| ROE | -2.64% |
| Dividend Yield | 0% |
| Profit Growth | -88.89% |
| Debt/Equity | — |
| Sales Growth | -68.18% |
| 52-Week Range | ₹30.27 — ₹78.7 |
| Sector | Finance |
| Book Value | ₹39.42 |
Strengths
- Trades at a 17% discount to stated book value (P/B 0.83), offering a margin of safety if the book is credible.
- Current price is close to the 52-week low of ₹30.27, suggesting much pessimism is already priced in.
- ROCE of 4.57% is positive even though ROE is negative, indicating some operational activity above capital cost.
- Small market cap of ₹9 Cr could attract a controlling stake buyer or corporate action if assets are genuinely valuable.
Concerns
- Latest quarter shows zero sales and zero net profit; the business appears effectively non-operating.
- Sales growth collapsed by 68.18% and profit growth by 88.89%, with no visible recovery trend.
- ROE is deeply negative at -2.64% and Piotroski F-Score is only 3/9, signaling weak financial health.
- Debt/Equity is N/A and promoter holding is N/A, leaving leverage and governance entirely unverifiable for an NBFC.
AI Analysis
At ₹32.58, this NBFC trades at a 17% discount to book value of ₹39.42, but that is where the conventional comfort ends. As Graham would say, a bargain only exists if the asset numbers are reliable and the business can eventually earn a return on those assets. Here ROE is -2.64%, and the latest quarter shows both sales and net profit at ₹0. Sales declined 68.18% and profits 88.89%. This is not a business compounding wealth; it is a shell that has stopped generating meaningful income. P/E is 0 because earnings are absent. P/B below 1 can be a value trap if the book value includes stale or impaired assets, especially in an NBFC where loan quality is everything. ROCE at 4.57% is unable to compensate equity holders after costs. The F-score of 3/9 reinforces weak fundamentals—poor profitability and minimal signs of recovery. The market cap is only ₹9 Cr, so institutional scrutiny is low and information is scarce. With no dividend, a retail investor gets no compensation while waiting. The 52-week range of ₹30.27 to ₹78.70 tells me this has already been repriced aggressively. As a Buffett/Graham investor, I avoid things I cannot understand or verify, and this has 'insufficient data' written all over it. The only possible interest is as a pure asset play: you are paying 0.83 rupee for a rupee of stated book value. But without positive earnings or a visible catalyst, you are relying on asset liquidation, takeover, or revival—none of which are apparent. I would not classify this as a quality business. It is a speculative asset play at best, suitable only for a small capital allocation after deep independent verification of asset quality.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer